Showing posts with label hematopoietic stem-cell transplantation (HSCT) therapy. Show all posts
Showing posts with label hematopoietic stem-cell transplantation (HSCT) therapy. Show all posts
Tuesday, February 17, 2015

Jazz Pharmaceuticals to present defibrotide results for hepatic VOD at BMT Tandem meetings

›
Jazz Pharmaceuticals plc (Nasdaq: JAZZ) announced today that researchers will present data on the use of defibrotide, an investigational m...